menu search

Clinical trial imaging market size worth us$ 2.17 billion by 2033 | cagr: 6.5%: fact.mr research

As per a new Fact.MR report, adoption of advanced technologies by pharma & biotech companies for the de...

January 17, 2023, 6:00 pm

We still think this is a bear market rally, says btig's jonathan krinsky

BTIG's Jonathan Krinsky joins 'Closing Bell Overtime' to discuss Caterpillar's surprising strength, proxies for an over-extended market and what to wa...

January 17, 2023, 5:20 pm

Moderna stock rallies 5% after respiratory virus vaccine trial meets endpoints

Moderna Inc. MRNA, -0.68% shares rallied in the extended session Tuesday after the biotech drug company...

January 17, 2023, 4:26 pm

Allogene therapeutics announces participation in two upcoming investor conferences

SOUTH SAN FRANCISCO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pion...

January 17, 2023, 4:05 pm

Clinical trials matching software market size to observe highest growth of usd 326.23 million with an excellent cagr of 13.50% by the end of 2028

Global Clinical Trials Matching Software Market Size, Share & COVID-19 Impact Analysis, By Component (Services and Software), By End User (Clinical Re...

January 17, 2023, 4:00 pm

Incyte (incy) up 7% in a year: will the momentum continue?

Incyte (INCY) outperforms the biotech industry in the past year and the momentum is anticipated to cont...

January 17, 2023, 11:18 am

Nexgel announces appointment of scott henry, managing director at roth capital partners, as a new independent director to its board

NEXGEL Inc (NASDAQ:NXGL) has announced the appointment of Scott Henry as a new independent director to the company's board effective immediately, he w...

January 17, 2023, 8:31 am

Vaxxinity: potential strong upsides ahead

We may not be at the end credits for COVID-19 virus. Shares of Vaxxinity, Inc., like most biotechs, have plummeted over the past year due to unprecede...

January 17, 2023, 7:58 am

Is ishares biotechnology etf (ibb) a strong etf right now?

Smart Beta ETF report for IBB...

January 17, 2023, 7:32 am

Omega therapeutics to present trial-in-progress poster for phase 1/2 mychelangelo™ i study at the american society of clinical oncology gastrointestinal cancers symposium

CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

January 17, 2023, 7:00 am

Should you invest in the first trust nyse arca biotechnology etf (fbt)?

Sector ETF report for FBT...

January 16, 2023, 7:31 am

10x genomics toolkit ‘at the fulcrum of innovation,' ceo says

This segment originally aired on January 10, 2023. 10x Genomics CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnol...

January 14, 2023, 5:00 am

Opiant pharmaceuticals: nano-cap buyout with interesting cvr thrown in

I love to get a CVR during a takeover process. This happens a lot when pharma or biotech companies with...

January 13, 2023, 2:26 pm

Neurocentria announces dr. thomas südhof to join the scientific advisory board

The appointment further strengthens the company’s scientific resources, including in neuronal function and synaptic transmission, which are central ...

January 13, 2023, 2:00 pm

Brookfield vs. blackstone: one clear high-yield winner

The alternative asset management industry is a $300 trillion addressable market that's doubling every five years. This industry is leading the charge ...

January 13, 2023, 7:30 am

Puma biotechnology to present at b. riley securities' 3rd annual oncology conference

LOS ANGELES--( BUSINESS WIRE )--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief...

January 12, 2023, 4:15 pm

2 biotechs making waves with a single product in their pipeline

Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise....

January 12, 2023, 10:10 am

Should you invest in the spdr s&p biotech etf (xbi)?

Sector ETF report for XBI...

January 12, 2023, 7:32 am

Exas nears key buy signal in active biotech etf arkg

There are a lot of reasons to be skeptical of tech investing right now since last year's broad market selloff — just how far is the Fed planning to ...

January 11, 2023, 5:11 pm

Ranking the 10 largest biotechs by pipeline

The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipe...

January 11, 2023, 12:34 pm


Search within

Pages Search Results: